KITLG and skin cancer: Further studies are yet needed to investigate the possibility of using SCF as a target for the developing of new antipigmentary lines or new targeted therapy for skin cancers by inhibiting SCF and for more clarification of the role of SCF in hyperpigmented benign and malignant skin lesions.